Skip to main content

Table 5 Acute adverse events recorded during concurrent high-dose intensity-modulated radiation therapy and docetaxel-based chemotherapy: dermatology/skin

From: Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial

 

Grade

Rash/dermatitis

Highest

Cohort 1

1

2

2

2

0

0

3

0

0

Cohort 2

1

1

1

2

0

0

 

3

0

0

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us